MedPath

RNA Biomarkers in Tissue Samples From Infants With Acute Myeloid Leukemia

Completed
Conditions
Leukemia
Registration Number
NCT01229124
Lead Sponsor
Children's Oncology Group
Brief Summary

RATIONALE: Studying samples of tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in RNA and identify biomarkers related to cancer.

PURPOSE: This research study is studying RNA biomarkers in tissue samples from infants with acute myeloid leukemia.

Detailed Description

OBJECTIVES:

* Sequence the microRNAs present in 20 infant AML samples as a pilot study.

* Compare microRNAs present in infant AML samples to infant ALL samples that are being concurrently sequenced in a separate study to identify lineage- and translocation-specific microRNAs.

OUTLINE: This is a multicenter study.

Previously collected cryopreserved cells from diagnosis are sequenced using reverse transcriptase-PCR.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Comparison of microRNAs present in infant AML samples to infant acute lymphoblastic leukemia samples to identify lineage- and translocation-specific microRNAs
Sequence of the microRNAs present in 20 infant acute myeloid leukemia (AML) samples
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath